ALL THINGS FITNESS AND WELLNESS

The practice of psychedelic assisted therapy is gaining traction across North America. Dr. Devon Christie is a physician, therapist and psychedelic researcher who joins the podcast to share insight on this practice for mental wellness in Canada.

Dr. Christie explains what psychedelic assisted therapy is, how it works, and who it can help. She is the Medical Director for Numinus Wellness Inc., which is one of the Canadian companies leading the charge to create safe access to these forms of treatment.

THE MINDSPACE PODCAST

"As therapists and guides, we're holding that space for the location of healing to be intrinsic to that person."

In this episode of the Mindspace podcast, Dr. Joe speaks with . Dr. Christie is a family physician with a focused practice in and the Senior Lead of Psychedelic Programs at .

PSYCHEDELICS TODAY

In this episode, Kyle interviews Dr. Devon Christie: Vancouver-based counsellor, instructor, and Therapeutic Services Director for Numinous Wellness Inc., and Will Siu, MD, DPhil: Los Angeles-based Psychiatrist. Both are MAPS-trained in MDMA-assisted psychotherapy and are currently co-investigators on a study investigating MDMA-assisted therapy for fibromyalgia.

PSYCHEDELICS TODAY

In this episode of Vital Psychedelic Conversations, Kyle Buller interviews Dr. Devon Christie: Senior Lead of Psychedelic Programs with Numinus Wellness, clinical instructor, counselor, and Co-Investigator and study therapist for a Canadian MAPS-sponsored trial investigating MDMA-assisted therapy for PTSD.

PSYCHEDELICS TODAY

In this episode, Joe interviews Senior Lead of Psychedelic Programs at Numinus, Dr. Devon Christie; and Medical Lead of the nonprofit, Roots To Thrive, Dr. Pamela Kryskow, about MDMA for fibromyalgia, nociplastic pain, & more.

PSYCHEDELICS TODAY

In this episode of Vital Psychedelic Conversations, David interviews Vital instructor, Dr. Devon Christie: Senior Lead of Psychedelic Programs at Numinus, MAPS-certified MDMA therapist, and now four-time guest; and Vital student, Emefa Boamah: coach, facilitator, and trauma-informed intuitive guide specializing in embodiment.

THE VANCOUVER SUN

Magic mushrooms, and other psychedelics, are suddenly everywhere — in clinical trials, being touted as a cure for treatment-resistant depression, PTSD, and end-of-life-anxiety.

Dr. Devon Christie, senior lead of psychedelic programs at Numinus in Vancouver, said Numinus has applied to Health Canada and been granted access approval to treat several patients with a synthetic version of psilocybin that is sourced through the lab that produces Health Canada-grade psilocybin.

PSYCHEDELIC HEALTH

Dr Devon Christie, Medical and Therapeutic Services Director with Numinus, speaks to Psychedelic Health about the representation of women in the field of psychedelics – from clinical research to high-level industry roles.

Research into psychedelics is showing the compound could hold promise as potential treatments for a number of conditions such as depression, anxiety and addiction.

VOGUE

The leading condition that psilocybin studies have focused on thus far is depression, for which it has been designated as a “breakthrough therapy” by the FDA.

“That means the evidence is now conclusive enough and the safety is there that it looks like psilocybin-assisted therapy for depression and treatment-resistant depression is potentially better than all the other options out there in terms of its efficacy,” explains Devon Christie, MD, medical and therapeutic services director for Numinus, a mental health care company with clinics and labs focused on psychedelic-assisted therapies.

THE SKIMM

Culd psychedelics — which have been studied as an alternative treatment for anxiety and PTSD — offer a path to eating disorder recovery? That’s something a number of researchers are exploring.

Among them: Dr. Devon Christie, a family physician and therapist who has personal experience with eating disorders (EDs). She’s the senior lead of psychedelic programs at Canadian research and psychotherapy company Numinus.

CBC NEWS

Research into psilocybin has found it can be an effective treatment for mental health conditions and addiction. A study published in February found it produced rapid and substantial antidepressants effects in patients with major depressive disorder but also pointed out little is still known about long-term outcomes.

Dr. Devon Christie, senior lead of psychedelic programs at Numinus, says in our regular state of consciousness, we have been conditioned to think in one specific way.

PORTLAND PSYCHEDELIC SOCIETY

Our panel of experts are both contributing members of MAPS, currently investigating the use of MDMA for the treatment of fibromyalgia pain. They also discuss other psychedelic assisted therapy for the treatment of chronic pain and other disorders.

PROACTIVE INVESTORS

Numinus Wellness Medical and Therapeutic Services Director for Numinus Dr. Devon Christie joined Steve Darling from Proactive to announce Health Canada has cleared an open-label safety and feasibility study evaluating MDMA-assisted therapy for post-traumatic stress disorder.

Dr Christie, who will serve as the study’s Qualified Investigator, tells Proactive during the study, research, medical and therapist staff at Numinus will collect data on the safety and effectiveness of MDMA-assisted therapy and then inform Health Canada.

GLOBAL NEWS

Hallucinogenic magic mushrooms were thought to have healing properties for centuries. It extended right up to the 1960s, when their use was banned during the so-called war on drugs. Today, they're going through a research renaissance, and scientists are revealing their potential to help people with mental health disorders, like anxiety, depression and PTSD.

Psychedelic-assisted psychotherapy, said Dr. Devon Christie, Numinus’ medical director, is opening a window for “people who are suffering, (and) who have oftentimes exhausted other options.”

CBC NEWS

A B.C. psychedelics company has received federal approval to use MDMA to treat more than a dozen people suffering from post-traumatic stress disorder.

"This study is about access, and about safety," said Dr. Devon Christie, Numinus medical and therapeutic services director.

PSYCHIATRIC TIMES

A growing body of scientific evidence suggests that mind-altering drugs, combined with psychotherapy, are effective treatments for some of the most stubborn psychiatric disorders.

Dr Christie is a family physician, a certified therapist, and medical and therapeutic services director at Numinus.